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To assess enhancer function in a physiologically relevant context, we first developed an optimized approach for highefficiency genomic editing in primary human (adult) mobilized CD34 + hematopoietic stem cells, whereby a single exposure to an engineered zinc finger 5 or transcription activator-like (TAL) effector 6 nuclease could produce 60-80% per-allele editing rates ( Supplementary Fig. 1a, Supplementary Tables 1 and 2 and Online Methods) within the population of edited cells. High-efficiency (70% of alleles) disruption of the BCL11A open reading frame in CD34 + cells followed by erythroid differentiation 7 yielded dramatic and highly reproducible elevation of γ-globin mRNA, providing a physiologically relevant readout for loss of BCL11A function ( Supplementary Fig. 1a,b ). By contrast, control nucleases that drove high-efficiency (>60%) targeted disruption of a neutral locus (AAVS1) 8 in the same cell type, coupled with the same differentiation protocol, had no impact on globin expression profiles ( Supplementary Fig. 1a,b) .
The BCL11A erythroid enhancer region encompasses three DNase I-hypersensitive sites (DHSs) located at +55 kb, +58 kb and +62 kb relative to the transcriptional start site (Fig. 1b) . TAL effector nucleases (TALENs) targeting each of these DHSs were delivered to human CD34 + cells, and TALEN delivery was followed by erythroid differentiation. Notably, nuclease-treated cells developed morphologically and physiologically indistinguishably from untreated cells, as reviewed by an expert hematologist (T.P.; Supplementary Fig. 2 ). Complete deletion of the +55 or +58 DHS reproducibly elevated γ-globin mRNA levels in mature CD34 + -derived erythroblasts, whereas deletion of the +62 DHS did not ( Supplementary Fig. 1c,d) . Of note, singlenucleotide polymorphisms in the latter DHS are associated with lower BCL11A expression and elevated γ-globin 3 ; however, it is unclear whether these variants are in fact causal.
We next asked whether it would be possible to identify the specific sequence elements within a DHS that underlie the functional effects of the entire element. For this purpose, we focused on the +58 DHS that showed the most potency in elevating γ-globin mRNA levels when deleted ( Supplementary Fig. 1d ). To map in vivo TF occupancy sites, we performed genomic footprinting 9 on human erythroblasts (Online Methods) and delineated eight TF footprints (FPs) covering 162 bp (53%) of the +58 DHS ( Fig. 1c) . To perform an initial functional scan, we used zincfinger nucleases (ZFNs) to disrupt five of the FPs, after which we functional footprinting of regulatory dna regulatory regions harbor multiple transcription factor (tf) recognition sites; however, the contribution of individual sites to regulatory function remains challenging to define. We describe an approach that exploits the error-prone nature of genome editing-induced double-strand break repair to map functional elements within regulatory dna at nucleotide resolution. We demonstrate the approach on a human erythroid enhancer, revealing single tf recognition sites that gate the majority of downstream regulatory function.
Transcription regulatory regions harbor the majority of human disease-associated sequence variants 1 , rendering them attractive targets for elucidating disease mechanisms via targeted genome engineering 2 . However, our understanding of the impact of regulatory DNA variation is severely limited by the difficulty of precisely assigning the functional contribution of individual nucleotides to phenotypic outcomes. The error-prone nature of doublestrand break repair triggered during targeted genome editing typically yields small deletions-or, more rarely, insertions-of variable size (1 to >10 nt, typically 2-6 nt). We reasoned that this byproduct of targeted genome editing could be systematically exploited to create a broad spectrum of variant regulatory alleles within a single experimental cycle and that by coupling these alleles to a functional readout (such as protein expression), we could pinpoint the contribution of specific nucleotides to regulatory activity ( Fig. 1a) .
To test this paradigm ( Fig. 1a) , we studied the erythroid enhancer region of BCL11A (Fig. 1b) , a transcriptional repressor of fetal hemoglobin production in adult erythroid cells 3 . Naturally brief communications performed erythroid differentiation and measured γ-globin mRNA levels. ZFNinduced lesions within footprint 5 (FP5) exhibited marked depletion of BCL11A mRNA and corresponding elevation of γ-globin levels irrespective of β-globin expression or normalization strategy ( Fig. 1d and Supplementary Fig. 3 ), indicating that a focused lesion in this regulatory element was sufficient to disrupt BCL11A enhancer function. Of note, FP5 overlaps a recognition sequence for the master regulator of erythropoiesis GATA1 (ref. 10; Fig. 1d ), and Encyclopedia of DNA Elements (ENCODE) data show GATA1 occupancy signal over this element in K562 erythroid cells 11 . Removal of the downstream portion of the +58 DHS using ZFNs provided independent confirmation of the functional role for FP5 in the regulation of γ-globin expression ( Supplementary Fig. 1e,f) .
Next, we tiled TALENs 6 across the +58 DHS ( Supplementary  Fig. 4a ) to address the possibility that our initial ZFN scan missed additional positions in this element critical for enhancer function owing either to ZFN nuclease tiling density or to target site-specific variation in cleavage activity. Targeted sequencing of edited CD34 + cells showed that the dense TALEN scan disrupted seven of the eight FPs in the +58 DHS and comprehensively edited the intervening sequences between these footprints ( Supplementary Fig. 4b and Supplementary Table 3 ), thus providing complete coverage of the targeted enhancer element. Notably, although we found a weak association between cleavage efficiency and γ-globin mRNA level ( Supplementary  Fig. 5a-c) , specific TALEN pairs were readily identified that induced edits causing increases in γ-globin mRNA expression irrespective of their cleavage rates ( Supplementary Fig. 5d and Online Methods). TALEN pair T12 (the cleavage site of which overlaps that of ZFN Z5) corroborated FP5 as a core functional element within the +58 DHS (Supplementary Fig. 5d ). Additionally, edits caused by TALENs T13 and T16 targeting the predicted binding sites for other well-described erythroid regulators, TAL1 (ref. 12 ) and RREB1 (ref. 13) ( Supplementary Fig. 4a) were associated with modest increases in γ-globin mRNA levels (Supplementary Fig. 5d ).
Because the double-strand break-repair process is resolved individually (and variably) on each DNA template copy within each cell, we reasoned that subtle variations in the position and extent of nuclease-triggered deletions could be analyzed to quantify the contribution of individual nucleotides to regulatory function. To quantify the spectrum and relative frequency of regulatory alleles, we sorted differentiated cells by their γ-globin protein expression levels and performed PCR amplification of DHS +58 within low-and high-γ-globin populations. We then conducted massively parallel sequencing of the reaction products ( Supplementary Fig. 6 and Supplementary Table 4) . The spectrum of regulatory alleles present in the populations of cells characterized by high versus low γ-globin expression revealed marked differences in the proportions of GATA1 recognition sequences that were lost as a result of nuclease treatment and subsequent break repair ( Fig. 2a,b ; 73.3% vs. 18.7%, high vs. low γ-globin). Of note, 46% of the edited targets in the low-γ-globin expression population maintained a strong match to the GATA1 consensus owing to the presence of a short repeat of adenosine nucleotides trailing the wild-type recognition sequence ( Fig. 2a) . Shifting the nuclease cleavage site by 1 bp resulted in a marked (21.8%) decrease in GATA1 recognition sequences in edited cells, manifesting in a reduction in BCL11A mRNA levels, and in stronger overall γ-globin induction in bulk cell populations, comparable to that evoked by nucleases that disrupt the BCL11A npg coding sequence ( Supplementary Fig. 7 and Supplementary  Table 5 ). These results indicate that the function of the erythroidspecific BCL11A enhancer is gated on the GATA1 recognition site in the +58 DHS.
The distinct spectra of allele frequencies observed in cells with high and low γ-globin expression indicated that γ-globin expression itself could be used as a quantitative molecular sensor for the function of the GATA1 binding site at single-base-pair resolution. To explore this further, we computed the per-nucleotide editing rate for each position surrounding the GATA1 consensus motif considering the frequencies of all genotypes observed. Edits associated with high γ-globin expression were markedly enriched for positions that covered the core GATA1 consensus motif, and the normalized editing rate observed in the cells with high γ-globin expression strikingly recapitulated an idealized GATA1 consensus sequence (Fig. 2c) . We additionally found increased rates of editing in both the upstream and downstream flanking sequences, indicating the presence of additional binding sites (for example, the GATA1 partner TAL1) that may serve to modulate GATA1 occupancy (Fig. 2c) ; indeed, the presence of additional factors is supported in the DNase I footprint (FP5) itself in addition to the clear conservation of its underlying sequence elements (Fig. 1c) . As noted above, the vast majority of genome-editing events found in cells with low γ-globin expression created alleles that did not ablate a functional GATA1 binding site.
Our results show that the functional impact of individual TF binding sites within cis-regulatory DNA can be efficiently interrogated by coupling the spectrum of alleles triggered by an engineered nuclease with expression of a downstream transcript or protein target. In the context of the distal BCL11A enhancer, our results pinpoint a single TF recognition site that can be targeted via genome editing to effect a potentially therapeutically meaningful outcome; editing the enhancer has functionally similar consequences on γ-globin mRNA expression to those of ablating the coding region of BCL11A itself ( Supplementary  Fig. 7c) , both of which do not measurably affect erythroid differentiation (Supplementary Fig. 2) .
Functional footprinting thus encompasses a simple and generalizable strategy to dissect the function of individual cis-regulatory elements such that any molecular sensor (i.e., protein, RNA, etc.) can be linked to the function of individual base pairs within noncoding DNA. Although methods exist that can assess the function of large libraries of synthetic alleles in both coding and feasibly noncoding DNA in vivo, the low efficiencies of allele integration achieved via homology-directed repair necessitate the use of large amounts of starting material and selectable markers to enrich for edited cells 14 . As such, application of these methods is limited to conventional cell lines. In contrast, functional footprinting does not rely on homology-directed repair for the introduction of a library of synthetic alleles, thus enabling application in primary cells and developmental systems for which material and time are important considerations. Furthermore, this paradigm is agnostic to particular genome-editing and downstream product-detection approaches; although the ZFN and TALEN platforms were used herein because of efficiency and downstream considerations such as the potential for therapeutic translation, such efforts could, in npg brief communications principle, rely on any genome-editing platform to attain a similar outcome 2 , subject to inherent limitations in design and efficiency. Similarly, functional footprinting is, in principle, compatible with any molecular readout (i.e., RNA, protein, post-translational modification levels, etc.) that can be efficiently sorted, and, critically, the detection of the sensor can occur on fixed (nonviable) cells, permitting use of a wide array of current and emerging technologies such as FACS on protein or RNA levels 15 .
methods Methods and any associated references are available in the online version of the paper. nature methods online methods Nuclease design and validation. ZFNs were designed and assembled using an archive of prevalidated two-finger modules 5 into expression vectors bearing obligate heterodimer forms of the FokI endonuclease 16 . TALENs were designed as described and cloned into expression vectors bearing truncated forms of the TALE domain 6 . In brief, the nucleases consist of a triple flag domain, a nuclear localization signal, the engineered DNA-binding domain and the FokI nuclease domain containing the obligate heterodimer mutations. The designed sequence recognition domains are provided in Supplementary Tables 1 and 2 . Nucleases were first assessed for editing efficiency by transient transfection of expression constructs into K562 cells followed by genotyping of the target locus using the Surveyor/Cel1 endonuclease 17 . ORFs for maximally active nucleases against each genomic position were recloned into an expression vector optimized for mRNA production bearing a 5′ and 3′ UTRs and a synthetic poly(A) signal. The mRNAs were generated using the mMessage mMachine T7 Ultra kit (Ambion) following the manufacturer's instructions. In vitro synthesis of nuclease mRNAs used either (i) a pVAX-based vector containing a T7 promoter and the nuclease proper, which requires enzymatic addition of a poly(A) tail following the in vitro transcription reaction or (ii) a pGEM-based vector containing a T7 promoter, a 5′ UTR, the nuclease proper, a 3′ UTR and a 64-bp poly(A) stretch.
